Evangelisches Krankenhaus Hamm gGmbH

Hamm 59063

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Leukemia, Non-small Cell Lung Cancer

Studies at this site

• A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) — Running, not enrolling
• Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) — Completed